| |
| |
|
| Insider
Information: |
Sindlev Rene |
| Relationship: |
Director, 10% Owner |
| City: |
2100 Copenhagen |
| State: |
G7 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
13,605,297 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$20,271,893 |
|
|
| Total
Shares |
13,605,297 |
|
|
| Total
Value |
$20,271,893 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -81.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enochian Biosciences Inc |
ENOB |
Director, 10% Owner |
|
0 |
2024-02-20 |
13,605,297 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2024-02-20 |
4 |
OE |
$0.53 |
$250,000 |
I/I |
471,699 |
13,605,297 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
701,260 |
13,133,598 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2023-06-26 |
4 |
A |
$0.53 |
$1,000,001 |
I/I |
1,886,794 |
12,432,338 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2023-03-17 |
4 |
A |
$1.14 |
$1,000,000 |
I/I |
877,193 |
10,545,544 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2022-06-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(253,493) |
0 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2022-05-18 |
4 |
B |
$8.00 |
$2,027,944 |
I/I |
253,493 |
128,493 |
2.25 |
% |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-07-30 |
4 |
OE |
$1.30 |
$4,019,999 |
I/I |
3,092,307 |
9,668,351 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-06-04 |
4 |
B |
$6.70 |
$211,050 |
I/I |
31,500 |
6,576,044 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-06-03 |
4 |
B |
$6.70 |
$268,000 |
I/I |
40,000 |
6,544,544 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-05-29 |
4 |
B |
$6.60 |
$132,000 |
I/I |
20,000 |
6,504,544 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-05-28 |
4 |
B |
$6.61 |
$239,282 |
I/I |
36,200 |
6,479,530 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-05-28 |
4/A |
B |
$6.61 |
$239,282 |
I/I |
36,200 |
6,484,544 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-05-24 |
4 |
B |
$6.25 |
$31,338 |
I/I |
5,014 |
6,448,344 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-05-22 |
4 |
B |
$5.76 |
$2,880 |
I/I |
500 |
6,443,330 |
2.17 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2019-05-21 |
4 |
B |
$5.75 |
$115,000 |
I/I |
20,000 |
6,442,830 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2018-12-27 |
4 |
OE |
$1.30 |
$1,700,001 |
I/I |
1,307,693 |
6,422,830 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2018-12-27 |
4 |
B |
$8.00 |
$743,744 |
I/I |
92,968 |
5,115,137 |
2.25 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2018-05-21 |
4 |
B |
$5.38 |
$6,994 |
I/I |
1,300 |
5,022,169 |
2.17 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2018-02-16 |
4 |
OE |
$1.30 |
$1,800,000 |
I/I |
1,250,000 |
5,020,869 |
0 |
- |
|
| ENOB |
Enochian Biosciences Inc |
Director |
– • • |
2016-03-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,770,869 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
